+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 65Years
All Genders
ID07009691

Study of Hydrogen Water to Reduce Fatigue and Improve Function in Adults with Chronic Fatigue Syndrome Using Heart Rate Variability

Led by Stony Brook University · Updated on 2025-06-08

50

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the use of hydrogen water, an over-the-counter magnesium-based supplement, to treat fatigue-related symptoms and improve function in adults with myalgic encephalomyelitischronic fatigue syndrome MECFS. This pilot study aims to identify heart rate variability HRV as a biological marker that can predict who will benefit from hydrogen water treatment. The study focuses on whether hydrogen water can reduce fatigue and enhance physical function in this population. Participants will follow a 10-day graduated dosing schedule of hydrogen water, followed by a standard daily dose over 16 weeks. The treatment involves consuming hydrogen water prepared from the supplement, which is known for its antioxidant properties. Researchers expect to observe two groups among participants those who improve and those who do not, based on their HRV measurements. During the study, participants will be assessed for fatigue severity using the Fatigue Severity Scale at 12 months. Heart rate variability will be monitored as a key biological measure to track health and well-being. The study will evaluate changes in fatigue symptoms and physical functioning over the treatment period, with safety and health status observed throughout participation, which may last up to one year.

CONDITIONS

Brief Title

Hydrogen Water Intervention With Heart Rate Variability as an Outcome Biomarker in ME/CFS

Research Team

F

Fred Friedberg, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here